Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

NCT03511235 is registered in ClinicalTrials.gov with Myriad Genetic Laboratories, Inc. as lead sponsor.

NCT NCT03511235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03511235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing
Lead sponsor
Myriad Genetic Laboratories, Inc.
Phase
Observational
Overall status
Completed
Start date
March 12, 2018
Completion date
July 31, 2018
Enrollment
774 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer